| [604] | 1 | English French  Notes   Complete/Exclude
 | 
|---|
 | 2 | ] New order(s) placed.                  
 | 
|---|
 | 3 | ] New DC order(s) placed.                       
 | 
|---|
 | 4 | Abnormal labs - [                       
 | 
|---|
 | 5 | Abnormal lab:                   
 | 
|---|
 | 6 | Order requires electronic signature.                    
 | 
|---|
 | 7 | ] Order placed:                         
 | 
|---|
 | 8 | ] Result available:                     
 | 
|---|
 | 9 | Procedure uses non-barium contrast media - abnormal biochem result:                     
 | 
|---|
 | 10 | Recent Cholecystogram:                  
 | 
|---|
 | 11 | Patient >65. Renal Results:                     
 | 
|---|
 | 12 | Missing Labs for Angiogram:                     
 | 
|---|
 | 13 | Patient allergic to contrast medias:                    
 | 
|---|
 | 14 | Recent Barium study:                    
 | 
|---|
 | 15 | WBC < 3.0 and/or ANC < 1.5 - pharmacy cannot fill clozapine order. Most recent results -                        
 | 
|---|
 | 16 | Clozapine orders require a CBC/Diff within past 7 days.  Please order CBC/Diff with WBC and ANC immediately.  Most recent results -                     
 | 
|---|
 | 17 |   Most recent results -                         
 | 
|---|
 | 18 | WBC between 3.0 and 3.5 with ANC >= 1.5 - please repeat CBC/Diff including WBC and ANC immediately and twice weekly.  Most recent results -                     
 | 
|---|
 | 19 | Clozapine - most recent results -                       
 | 
|---|
 | 20 | Aminoglycoside - est. CrCl:                     
 | 
|---|
 | 21 | Patient may be                  
 | 
|---|
 | 22 | Est. CrCl:                      
 | 
|---|
 | 23 |  ordered - adjust diet accordingly.                     
 | 
|---|
 | 24 | Procedure uses non-barium contrast media and patient is taking glucophage.                      
 | 
|---|
 | 25 | Potential polypharmacy - patient currently receiving                    
 | 
|---|
 | 26 | Labs resulted - [                       
 | 
|---|
 | 27 | Glucophage - Creatinine results:                        
 | 
|---|
 | 28 | Glucophage - no serum creatinine within past                    
 | 
|---|
 | 29 | ] Lab threshold exceeded - [                    
 | 
|---|
 | 30 | Patient has no allergy assessment.                      
 | 
|---|
 | 31 | Duplicate opioid medications:                   
 | 
|---|
 | 32 | When the transport routine encounters locally                   
 | 
|---|
 | 33 | altered rule data at a site, do you want to:                    
 | 
|---|
 | 34 | (O)verwrite, (D)isplay, or (A)sk the site ?                     
 | 
|---|
 | 35 | Locally altered data will be overwritten without asking.                        
 | 
|---|
 | 36 | Locally altered data will be displayed only.                    
 | 
|---|
 | 37 | Sites will be asked before locally altered data is overwritten.                 
 | 
|---|
 | 38 | Enter Patch ID (ex. OR*3*96):                   
 | 
|---|
 | 39 | OR*                     
 | 
|---|
 | 40 |    v = Package Version.                 
 | 
|---|
 | 41 |  ppp = Patch Number.                    
 | 
|---|
 | 42 | (Delete after Install of                        
 | 
|---|
 | 43 | Scanning for old rule transport routines...                     
 | 
|---|
 | 44 | No old rule transport routines found...                 
 | 
|---|
 | 45 | These routines will be deleted and overwritten.                 
 | 
|---|
 | 46 |  Do you want to proceed?                        
 | 
|---|
 | 47 | Old rule transport routines not deleted (^%ZOSF(                        
 | 
|---|
 | 48 |    Not Deleted...                       
 | 
|---|
 | 49 | Select an                       
 | 
|---|
 | 50 |   ***** Already selected for transport. *****                   
 | 
|---|
 | 51 | None Selected for transport                     
 | 
|---|
 | 52 | Already selected for transport:                 
 | 
|---|
 | 53 | Press <Enter> to continue...                    
 | 
|---|
 | 54 |  added to list.                 
 | 
|---|
 | 55 |  removed from list.                     
 | 
|---|
 | 56 | Select a                        
 | 
|---|
 | 57 |  selected for transport.                        
 | 
|---|
 | 58 | ORDER CHECK                     
 | 
|---|
 | 59 | OCX MDD                         
 | 
|---|
 | 60 |   unknown lookup error.                 
 | 
|---|
 | 61 |   could not resolve name.                       
 | 
|---|
 | 62 |     End Transport.                      
 | 
|---|
 | 63 |  already existed.                       
 | 
|---|
 | 64 |    record missing...                    
 | 
|---|
 | 65 | Unresolved subscript.                   
 | 
|---|
 | 66 |    ^DIE filer data error...                     
 | 
|---|
 | 67 |     ...Correct data Filed                       
 | 
|---|
 | 68 | Rule Transport aborted, version mismatch.                       
 | 
|---|
 | 69 |    Rule Transport Version: |CVER|                       
 | 
|---|
 | 70 | Order Check Expert System Rule Transporter                      
 | 
|---|
 | 71 |  data filing error                      
 | 
|---|
 | 72 | Some expert system rules may be incomplete.                     
 | 
|---|
 | 73 |  No data filing errors.                 
 | 
|---|
 | 74 | Transport Finished...                   
 | 
|---|
 | 75 | ]  ERROR - RECORD NOT FOUND                     
 | 
|---|
 | 76 | ACD EXTRACT V10.1                       
 | 
|---|
 | 77 |  Available record layouts:                      
 | 
|---|
 | 78 |   1) VAACCR Record Layout Version 10.1 (VA Registry)                    
 | 
|---|
 | 79 |   2) NAACCR State Record Layout Version 10.1                    
 | 
|---|
 | 80 |  Select record layout:                  
 | 
|---|
 | 81 | Select the record layout to use                 
 | 
|---|
 | 82 | VACCR EXTRACT V10.1                     
 | 
|---|
 | 83 | STATE EXTRACT V10.1                     
 | 
|---|
 | 84 |     DISPLAY/PRINT on-line instructions                  
 | 
|---|
 | 85 | STATE REPORTING ACOS INFOA                      
 | 
|---|
 | 86 | PRIMARY ACOS INFO (850)                 
 | 
|---|
 | 87 |  Select start date:                     
 | 
|---|
 | 88 |  Select end date:                       
 | 
|---|
 | 89 |  Analytic cases only                    
 | 
|---|
 | 90 |  Answer 'YES' if you want only analytic cases (CLASS OF CASE 0-2) extracted.                    
 | 
|---|
 | 91 |  Answer  'NO' if you want all cases (analytic and non-analytic) extracted.                      
 | 
|---|
 | 92 | |Please activate your PC capture program.  The data will be sent|                       
 | 
|---|
 | 93 | |        in 30 seconds or when you press the return key.        |                       
 | 
|---|
 | 94 | No records extracted.                   
 | 
|---|
 | 95 | ACoS Report Print                       
 | 
|---|
 | 96 | State Extract Print                     
 | 
|---|
 | 97 | Report Canceled!                        
 | 
|---|
 | 98 | Report Queued!                  
 | 
|---|
 | 99 |  These are your current settings:                       
 | 
|---|
 | 100 |  Record layout.......................:                  
 | 
|---|
 | 101 |  Facility Identification Number (FIN):                  
 | 
|---|
 | 102 |  State to be extracted...............:                  
 | 
|---|
 | 103 |  Accession Year......................:                  
 | 
|---|
 | 104 |  Start date..........................:                  
 | 
|---|
 | 105 |  End date............................:                  
 | 
|---|
 | 106 |  Analytic cases only.................:                  
 | 
|---|
 | 107 |  Are these settings correct                     
 | 
|---|
 | 108 |  Accession Year:                        
 | 
|---|
 | 109 | Facility Identification Number (FIN)                    
 | 
|---|
 | 110 | The site paramaters record is being edited by another user.                     
 | 
|---|
 | 111 | Press ENTER to Continue or                      
 | 
|---|
 | 112 |  to Quit:                       
 | 
|---|
 | 113 | Col#                    
 | 
|---|
 | 114 | Data item                       
 | 
|---|
 | 115 | Data Value                      
 | 
|---|
 | 116 | ONC(                    
 | 
|---|
 | 117 | ICDO-TOPOGRAPHY is not defined                  
 | 
|---|
 | 118 | .........: Surgery performed                    
 | 
|---|
 | 119 | .........: Radiation performed                  
 | 
|---|
 | 120 | The Accession Year is not 1995.                 
 | 
|---|
 | 121 | The Diagnostic Confirmation code is not 1.                      
 | 
|---|
 | 122 | The Class of Case code is not 0, 1 or 2.                        
 | 
|---|
 | 123 | Date DX and/or First Treatment Date not in 1995.                        
 | 
|---|
 | 124 | Select table                    
 | 
|---|
 | 125 | This primary does not satisfy the PCE eligibility criteria:                     
 | 
|---|
 | 126 | Patient Care Evaluation Study of Cancers of the Urinary Bladder                 
 | 
|---|
 | 127 | ACCESSION/SEQUENCE NUMBER                       
 | 
|---|
 | 128 | CLASS OF CASE                   
 | 
|---|
 | 129 | REFERRED FOR TREATMENT TO                       
 | 
|---|
 | 130 | ZIP AT DIAGNOSIS                        
 | 
|---|
 | 131 | SPANISH ORIGIN                  
 | 
|---|
 | 132 | PRIMARY PAYER AT DIAGNOSIS                      
 | 
|---|
 | 133 | PATIENT HISTORY OF OTHER CANCER                 
 | 
|---|
 | 134 | FAMILY HISTORY OF CANCER                        
 | 
|---|
 | 135 | SMOKING HISTORY                 
 | 
|---|
 | 136 | DURATION OF SMOKING HISTORY                     
 | 
|---|
 | 137 | DURATION OF SMOKE-FREE HISTORY                  
 | 
|---|
 | 138 | TABLE I - GENERAL INFORMATION                   
 | 
|---|
 | 139 | ACCESSION/SEQUENCE NUMBER.....:                         
 | 
|---|
 | 140 | CLASS OF CASE.................:                         
 | 
|---|
 | 141 | 300REFERRED FOR TREATMENT TO.....                       
 | 
|---|
 | 142 | 9ZIP AT DIAGNOSIS..............                 
 | 
|---|
 | 143 | DATE OF BIRTH.................:                         
 | 
|---|
 | 144 | 9SPANISH ORIGIN................                 
 | 
|---|
 | 145 | 18PRIMARY PAYER AT DIAGNOSIS....                        
 | 
|---|
 | 146 | 301LENGTH OF STAY................                       
 | 
|---|
 | 147 | PATIENT HISTORY OF OTHER CANCER:                        
 | 
|---|
 | 148 | 305  HEAD AND NECK...............                       
 | 
|---|
 | 149 | FAMILY HISTORY OF CANCER:                       
 | 
|---|
 | 150 | 314SMOKING HISTORY (PACKS/DAY)...                       
 | 
|---|
 | 151 | 315DURATION OF SMOKING HISTORY...                       
 | 
|---|
 | 152 | 316DURATION OF SMOKE-FREE HISTORY                       
 | 
|---|
 | 153 | GO TO:                  
 | 
|---|
 | 154 | CLINICAL DETECTION                      
 | 
|---|
 | 155 | ONSET OF SYMPTOMS                       
 | 
|---|
 | 156 | DURATION OF SYMPTOMS BEFORE DIAGNOSIS                   
 | 
|---|
 | 157 | DIAGNOSTIC PROCEDURES                   
 | 
|---|
 | 158 | DATE OF INITIAL DIAGNOSIS                       
 | 
|---|
 | 159 | SPECIALTY MAKING DIAGNOSIS                      
 | 
|---|
 | 160 | PRIMARY SITE (ICD-O-2)                  
 | 
|---|
 | 161 | HISTOLOGY (ICD-O-2)                     
 | 
|---|
 | 162 | TABLE II- DIAGNOSTIC INFORMATION                        
 | 
|---|
 | 163 | CLINICAL DETECTION:                     
 | 
|---|
 | 164 | 317  GROSS HEMATURIA................                    
 | 
|---|
 | 165 | 318  MICROSCOPIC HEMATURIA..........                    
 | 
|---|
 | 166 | 319  URINARY FREQUENCY..............                    
 | 
|---|
 | 167 | 320  BLADDER IRRITABILITY...........                    
 | 
|---|
 | 168 | 323ONSET OF SYMPTOMS................                    
 | 
|---|
 | 169 | DURATION OF SYMPTOMS (months) BEFORE DIAGNOSIS:                 
 | 
|---|
 | 170 | 324  GROSS HEMATURIA................                    
 | 
|---|
 | 171 | DIAGNOSTIC PROCEDURES:                  
 | 
|---|
 | 172 | 326  BIMANUAL EXAMINATION OF BLADDER                    
 | 
|---|
 | 173 | 327  CYSTOSCOPY WITH BIOPSY.........                    
 | 
|---|
 | 174 | 328  CYSTOSCOPY WITHOUT BIOPSY......                    
 | 
|---|
 | 175 | 329  FLOW CYTOMETRY.................                    
 | 
|---|
 | 176 | 330  INTRAVENOUS PYELOGRAM..........                    
 | 
|---|
 | 177 | 331  URINE CYTOLOGY.................                    
 | 
|---|
 | 178 | DATE OF INITIAL DIAGNOSIS........:                      
 | 
|---|
 | 179 | 334SPECIALTY MAKING DIAGNOSIS.......                    
 | 
|---|
 | 180 | PRIMARY SITE (ICD-O-2)...........:                      
 | 
|---|
 | 181 | HISTOLOGY (ICD-O-2)..............:                      
 | 
|---|
 | 182 | STAGING PROCEDURES                      
 | 
|---|
 | 183 | PRESENCE OF HYDRONEPHROSIS                      
 | 
|---|
 | 184 | TUMOR SIZE (mm)                 
 | 
|---|
 | 185 | PRESENCE OF MULTIPLE TUMORS                     
 | 
|---|
 | 186 | REGIONAL NODES EXAMINED                 
 | 
|---|
 | 187 | REGIONAL NODES POSITIVE                 
 | 
|---|
 | 188 | SITES OF DISTANT METASTASIS                     
 | 
|---|
 | 189 | AJCC CLINICAL STAGE (cTNM)                      
 | 
|---|
 | 190 | AJCC PATHOLOGIC STAGE (pTNM)                    
 | 
|---|
 | 191 | STAGED BY                       
 | 
|---|
 | 192 | TABLE III- EXTENT OF DISEASE AND AJCC STAGE                     
 | 
|---|
 | 193 | STAGING PROCEDURES:                     
 | 
|---|
 | 194 | 335  ABDOMINAL ULTRASOUND.........                      
 | 
|---|
 | 195 | 336  BONE IMAGING.................                      
 | 
|---|
 | 196 | 338  CT CHEST/LUNG................                      
 | 
|---|
 | 197 | 339  CT ABDOMEN/PELVIS............                      
 | 
|---|
 | 198 | 340  CT OTHER.....................                      
 | 
|---|
 | 199 | 341  MRI PELVIS/ABDOMEN...........                      
 | 
|---|
 | 200 | 342  MRI OTHER....................                      
 | 
|---|
 | 201 | 344PRESENCE OF HYDRONEPHROSIS.....                      
 | 
|---|
 | 202 | 29TUMOR SIZE (mm)................                       
 | 
|---|
 | 203 | 345PRESENCE OF MULTIPLE TUMORS....                      
 | 
|---|
 | 204 | 33REGIONAL NODES EXAMINED........                       
 | 
|---|
 | 205 | 32REGIONAL NODES POSITIVE........                       
 | 
|---|
 | 206 | SITES OF DISTANT METASTASIS:                    
 | 
|---|
 | 207 | 34  SITE OF DISTANT METASTASIS #1                       
 | 
|---|
 | 208 |   SITE OF DISTANT METASTASIS #2: None                   
 | 
|---|
 | 209 |   SITE OF DISTANT METASTASIS #3: None                   
 | 
|---|
 | 210 | 34.1  SITE OF DISTANT METASTASIS #2                     
 | 
|---|
 | 211 | 34.2  SITE OF DISTANT METASTASIS #3                     
 | 
|---|
 | 212 | AJCC CLINICAL STAGE (cTNM):                     
 | 
|---|
 | 213 | 38AJCC STAGE.....................                       
 | 
|---|
 | 214 | AJCC PATHOLOGIC STAGE (pTNM):                   
 | 
|---|
 | 215 | 88AJCC STAGE.....................                       
 | 
|---|
 | 216 | STAGED BY:                      
 | 
|---|
 | 217 | 19  CLINICAL STAGE....................                  
 | 
|---|
 | 218 | 89  PATHOLOGIC STAGE..................                  
 | 
|---|
 | 219 | DATE OF INITIAL TREATMENT                       
 | 
|---|
 | 220 | PROTOCOL ELIGIBILITY STATUS                     
 | 
|---|
 | 221 | MANAGING PHYSICIANS                     
 | 
|---|
 | 222 | RADIATION THERAPY                       
 | 
|---|
 | 223 | TABLE IV - FIRST COURSE OF TREATMENT                    
 | 
|---|
 | 224 | DATE OF INITIAL TREATMENT...........:                   
 | 
|---|
 | 225 | 346PROTOCOL ELIGIBILITY STATUS.........                 
 | 
|---|
 | 226 | MANAGING PHYSICIANS:                    
 | 
|---|
 | 227 | 347  PRIMARY PHYSICIAN.................                 
 | 
|---|
 | 228 | 348  SECONDARY PHYSICIAN...............                 
 | 
|---|
 | 229 | SURGERY:                        
 | 
|---|
 | 230 |   DATE OF SURGERY...................:                   
 | 
|---|
 | 231 |   TYPE OF SURGERY...................:                   
 | 
|---|
 | 232 |   TUMOR RESECTION DURING TURB.......: Not applicable                    
 | 
|---|
 | 233 | 349  TUMOR RESECTION DURING TURB.......                 
 | 
|---|
 | 234 |   TYPE OF URINARY DIVERSION.........: Not applicable                    
 | 
|---|
 | 235 | 350  TYPE OF URINARY DIVERSION.........                 
 | 
|---|
 | 236 |   PELVIC LYMPH NODE DISSECTION......: Not applicable                    
 | 
|---|
 | 237 | 351  PELVIC LYMPH NODE DISSECTION......                 
 | 
|---|
 | 238 |   SURGICAL COMPLICATIONS:                       
 | 
|---|
 | 239 |     BLEEDING REQUIRING TRANSFUSION..: No                        
 | 
|---|
 | 240 |     DEEP VENOUS THROMBOSIS..........: No                        
 | 
|---|
 | 241 |     MYOCARDIAL INFARCTION/ARRHYTHMIA: No                        
 | 
|---|
 | 242 |     PELVIC ABSCESS..................: No                        
 | 
|---|
 | 243 |     PNEUMONIA REQUIRING ANTIBIOTICS.: No                        
 | 
|---|
 | 244 |     POST-OPERATIVE DEATH (30 DAYS)..: No                        
 | 
|---|
 | 245 |     PULMONARY EMBOLISM/THROMBOSIS...: No                        
 | 
|---|
 | 246 | 352    BLEEDING REQUIRING TRANSFUSION..                 
 | 
|---|
 | 247 | 353    DEEP VENOUS THROMBOSIS..........                 
 | 
|---|
 | 248 | 354    MYOCARDIAL INFARCTION/ARRHYTHMIA                 
 | 
|---|
 | 249 | 355    PELVIC ABSCESS..................                 
 | 
|---|
 | 250 | 356    PNEUMONIA REQUIRING ANTIBIOTICS.                 
 | 
|---|
 | 251 | 357    POST-OPERATIVE DEATH (30 DAYS)..                 
 | 
|---|
 | 252 | 358    PULMONARY EMBOLISM/THROMBOSIS...                 
 | 
|---|
 | 253 | RADIATION THERAPY:                      
 | 
|---|
 | 254 |   RADIATION THERAPY.................:                   
 | 
|---|
 | 255 |   DATE RADIATION THERAPY STARTED....:                   
 | 
|---|
 | 256 |   DATE RADIATION THERAPY ENDED......: 00/00/0000                        
 | 
|---|
 | 257 |   TOTAL RAD (cGy/rad) DOSE..........: 00000                     
 | 
|---|
 | 258 |   REGIONAL TREATMENT MODALITY.......: No radiation therapy                      
 | 
|---|
 | 259 |   RADIATION COMPLICATIONS:                      
 | 
|---|
 | 260 |     URINARY INCONTINENCE............: Not applicable                    
 | 
|---|
 | 261 |     HEMATURIA.......................: Not applicable                    
 | 
|---|
 | 262 |     RADIATION BOWEL INJURY..........: Not applicable                    
 | 
|---|
 | 263 |   DATE RADIATION THERAPY ENDED......: 99/99/9999                        
 | 
|---|
 | 264 |   TOTAL RAD (cGy/rad) DOSE..........: 99999                     
 | 
|---|
 | 265 |   REGIONAL TREATMENT MODALITY.......: Unknown                   
 | 
|---|
 | 266 |     URINARY INCONTINENCE............: Unknown                   
 | 
|---|
 | 267 |     RADIATION BOWEL INJURY..........: Unknown                   
 | 
|---|
 | 268 | 361  DATE RADIATION THERAPY ENDED......                 
 | 
|---|
 | 269 | 362  TOTAL RAD (cGy/rad) DOSE..........                 
 | 
|---|
 | 270 | 363  REGIONAL TREATMENT MODALITY.......                 
 | 
|---|
 | 271 | 364    URINARY INCONTINENCE............                 
 | 
|---|
 | 272 | 366    RADIATION BOWEL INJURY..........                 
 | 
|---|
 | 273 | CHEMOTHERAPY:                   
 | 
|---|
 | 274 |   DATE CHEMOTHERAPY STARTED.........:                   
 | 
|---|
 | 275 |   DATE CHEMOTHERAPY ENDED...........: 00/00/0000                        
 | 
|---|
 | 276 |   ROUTE CHEMOTHERAPY ADMINISTERED...: No chemotherapy                   
 | 
|---|
 | 277 |   TYPES OF AGENTS ADMINISTERED:                 
 | 
|---|
 | 278 |     ADRIAMYCIN......: None      IFOSFAMIDE......: None                  
 | 
|---|
 | 279 |     CARBOPLATINUM...: None      METHOTREXATE....: None                  
 | 
|---|
 | 280 |     CISPLATIN.......: None      TAXOL...........: None                  
 | 
|---|
 | 281 |     CYCLOPHOSPHAMIDE: None      THIOTEPA........: None                  
 | 
|---|
 | 282 |     5-FLUOROURACIL..: None      VINBLASTINE.....: None                  
 | 
|---|
 | 283 |     GALLIUM NITRATE.: None      OTHER...........: None                  
 | 
|---|
 | 284 |   INDICATION FOR ADMIN OF AGENTS....: No agents administered, NA                        
 | 
|---|
 | 285 |   REASON CHEMOTHERAPY STOPPED.......: Treatment completed, NA                   
 | 
|---|
 | 286 |   DATE CHEMOTHERAPY ENDED...........: 99/99/9999                        
 | 
|---|
 | 287 |   ROUTE CHEMOTHERAPY ADMINISTERED...: Unknown                   
 | 
|---|
 | 288 |     ADRIAMYCIN......: Unknown   IFOSFAMIDE......: Unknown                       
 | 
|---|
 | 289 |     CARBOPLATINUM...: Unknown   METHOTREXATE....: Unknown                       
 | 
|---|
 | 290 |     CISPLATIN.......: Unknown   TAXOL...........: Unknown                       
 | 
|---|
 | 291 |     CYCLOPHOSPHAMIDE: Unknown   THIOTEPA........: Unknown                       
 | 
|---|
 | 292 |     5-FLUOROURACIL..: Unknown   VINBLASTINE.....: Unknown                       
 | 
|---|
 | 293 |     GALLIUM NITRATE.: Unknown   OTHER...........: Unknown                       
 | 
|---|
 | 294 |   INDICATION FOR ADMIN OF AGENTS....: Unknown                   
 | 
|---|
 | 295 |   REASON CHEMOTHERAPY STOPPED.......: Unknown                   
 | 
|---|
 | 296 | 367  DATE CHEMOTHERAPY ENDED...........                 
 | 
|---|
 | 297 | 368  ROUTE CHEMOTHERAPY ADMINISTERED...                 
 | 
|---|
 | 298 | 374    GALLIUM NITRATE.................                 
 | 
|---|
 | 299 | 380    OTHER AGENT.....................                 
 | 
|---|
 | 300 | 381  INDICATION FOR ADMIN OF AGENTS....                 
 | 
|---|
 | 301 | 382  REASON CHEMOTHERAPY STOPPED.......                 
 | 
|---|
 | 302 | IMMUNOTHERAPY:                  
 | 
|---|
 | 303 | ####################    ####################    ####################    
 | 
|---|
 | 304 | ####################    ####################    ####################    
 | 
|---|
 | 305 | ####################    ####################    ####################    
 | 
|---|
 | 306 | ####################    ####################    ####################    
 | 
|---|
 | 307 | ####################    ####################    ####################    
 | 
|---|